title: Long-term safety of ranibizumab in neovascular age-related macular degeneration.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Matonti
authors.forename: Jean Christophe
authors.initials: JC
authors.lastname: Courjaret
authors.forename: Louis
authors.initials: L
authors.lastname: Hoffart
authors.forename: Franck
authors.initials: F
authors.lastname: Amouyal
authors.forename: Danièle
authors.initials: D
authors.lastname: Denis
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized